The Future of Healthcare: Part II, The Waiting Room of Tomorrow
In Part II of our expert series on the future of healthcare and The Patient, OneMedSentinel sits down with Dr. Cynthia Haines to discuss the digitization of the waiting room.
OneMedForum NY 2012 Sponsor Aptiv Solutions Educates the Market on Adaptive Clinical Trials
Aptiv Solutions is a full-service international CRO with proven expertise in supporting global clinical trials for biopharmaceutical and medical device companies. Their trials span the development lifecycle from first-in-human through regulatory approval and beyond.
Compassionate Use of Pluristem’s PLX Cells Saves the Life of a Child after Bone Marrow Transplantation Failure
IM Injections of PLX Cells Causing a Dramatic Recovery of Blood Forming Cells.
Editor’s Note May 22, 2012
This week, OneMedPlace brings you the final interview in our MPR series. A thorough discussion with design engineers Leon Marucchi and Katie McHugh give us […]
Dr. James Tong of Tianyin Pharmaceuticals Discusses New Manufacturing Facility and Promising Future Milestones
Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in modernized traditional Chinese medicines and branded generics.
July 12, 2012 OneMedForum New York
OneMedForum NY2012 To Feature Expert Panels, Investor Guides and Disruptive Technologies from Emerging Companies. The 3rd Annual Healthcare Investment Conference Will Be Held in New York City, July 12th, 2012
Neurometrix Focuses on Diabetes-Related Nerve Damage
President and CEO, Dr. Shai Gozani is interviewed by OneMedRadio where he discusses the Sensus Pain Therapy device.
June 18-21, 2012 BIO International Convention
BIO International Convention is a service of and hosted by the Biotechnology Industry Organization (BIO). BIO represents more than 1,100 biotechnology companies, academic institutions, state […]
This Week in Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
NanoViricides Announces Issuance of a Fundamental Patent in the USA
NanoViricides, Inc. (OTC BB: NNVC) announced that a fundamental patent, on which the nanoviricides® technology is based, is due to be issued in the USA on May 8, 2012. The issuance notification was received from the US Patents and Trademarks Office last week.